You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mesothelioma, Malignant

Showing 1 - 25 of 4,277
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Pleural Mesothelioma Trial (Proton beam therapy)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Proton beam therapy
  • (no location specified)
Dec 14, 2022

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in

Recruiting
  • Malignant Pleural Mesothelioma, Advanced
  • Oncolytic Adenovirus H101
  • Programmed death receptor-1 inhibitor
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Sep 2, 2023

Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Cairo, Egypt
    Ain Shams University Hospital
Dec 20, 2022

Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma, Mesothelioma Trial in United States (Pemetrexed, Cisplatin,

Recruiting
  • Malignant Peritoneal Mesothelioma
  • +4 more
  • Chicago, Illinois
  • +10 more
Sep 21, 2023

Mesotheliomas Pleural Trial in Amsterdam (Pembrolizumab, Lenvatinib)

Recruiting
  • Mesotheliomas Pleural
  • Amsterdam, Noord-Holland, Netherlands
    Antoni van Leeuwenhoekziekenhuis (NKI-AVL)
Jan 13, 2023

Patients With Mesothelioma

Not yet recruiting
  • Mesothelioma
    • (no location specified)
    Apr 21, 2023

    Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)

    Active, not recruiting
    Has Results
    • Malignant Pleural Mesothelioma
    • Mesothelioma
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 5, 2023

    Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

    Not yet recruiting
    • Mesothelioma
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 1, 2023

    Biological Characteristics of Mesothelioma Patients

    Completed
    • Malignant Mesothelioma
      • Rozzano, Milano, Italy
      • +1 more
      Sep 8, 2022

      Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

      Not yet recruiting
      • Malignant Pleural Mesothelioma
      • Dendritic cell vaccination
      • +2 more
      • Edegem, Antwerp, Belgium
      • +2 more
      Feb 28, 2023

      Lung Cancer, Mesothelioma Trial in Houston (Alisertib)

      Completed
      Has Results
      • Lung Cancer
      • Mesothelioma
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Sep 23, 2022

      Mesothelioma Trial (Magnesium sulfate, Normal Saline)

      Not yet recruiting
      • Mesothelioma
      • Magnesium sulfate
      • Normal Saline
      • (no location specified)
      Feb 15, 2023

      Ovarian Cancer, Cholangiocarcinoma Recurrent, Mesothelioma, Malignant Trial (SynKIR-110, Autologous T cells Transduced with

      Not yet recruiting
      • Ovarian Cancer
      • +2 more
      • SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR
      • (no location specified)
      Oct 5, 2022

      Malignant Pleural Mesothelioma, Chemo Effect Trial in Cairo (hyperthermic intrathoracic chemo)

      Recruiting
      • Malignant Pleural Mesothelioma
      • Chemotherapy Effect
      • hyperthermic intrathoracic chemotherapy
      • Cairo, Egypt
        Ain Shams University hospitals
      Aug 18, 2022

      Pleural Mesothelioma Trial in Guangzhou (Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin)

      Not yet recruiting
      • Pleural Mesothelioma
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Jul 3, 2023

      Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, nab-paclitaxel)

      Completed
      Has Results
      • Mesothelioma
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jul 28, 2022

      Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

      Completed
      • Pleural Mesothelioma
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jan 8, 2023

      Cancer, Cancer, Lung, Cancer of Lung Trial in Worldwide (UV1 vaccine + leukine, ipilimumab, nivolumab)

      Active, not recruiting
      • Cancer
      • +6 more
      • UV1 vaccine + leukine
      • +2 more
      • Perth, Australia
      • +6 more
      Jan 23, 2023

      Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma

      Recruiting
      • Mesothelioma, Malignant
        • Shinjuku-ku, Tokyo, Japan
          Local Institution
        Apr 5, 2022

        Peritoneal Malignant Mesothelioma Trial in Rotterdam (Intraperitoneal Paclitaxel Solution (Ml))

        Recruiting
        • Peritoneal Malignant Mesothelioma
        • Intraperitoneal Paclitaxel Solution (Ml)
        • Rotterdam, Zuid-Holland, Netherlands
          Erasmus Medical Center
        Jul 7, 2022

        Malignant Pleural Mesothelioma Trial in United States (E-Nose testing, Research blood)

        Recruiting
        • Malignant Pleural Mesothelioma
        • E-Nose testing
        • Research blood
        • Basking Ridge, New Jersey
        • +6 more
        Sep 8, 2023

        Mesothelioma Trial in Durham, Houston (Durvalumab / tremelimumab, Platinum cisplatin or carboplatin and pemetrexed chemo plus

        Not yet recruiting
        • Mesothelioma
        • Durvalumab / tremelimumab
        • Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab
        • Durham, North Carolina
        • +1 more
        Jul 5, 2023

        TTFields in General Routine Clinical Care in Pleural

        Not yet recruiting
        • Pleural Mesothelioma
        • TTFields
        • (no location specified)
        Sep 9, 2022

        Mesothelioma, Malignant Trial in Leicester (Niraparib Oral Product, Active Symptom Control)

        Recruiting
        • Mesothelioma, Malignant
        • Niraparib Oral Product
        • Active Symptom Control
        • Leicester, United Kingdom
          University Hospitals of Leicester NHS Trust, Royal Leicester Inf
        Jul 20, 2022

        Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, ipilimumab)

        Recruiting
        • Mesothelioma
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jul 6, 2022